Parra‐Guiza 2018.
Study characteristics | ||
Methods | RCT | |
Participants | Inclussion criteria:
Exclusion criteria: |
|
Interventions | Intervention 1: 5HT3 antagonist (Comparison 1)
Intervention 2: corticosteroid (Comparison 3)
Comparator: placebo
|
|
Outcomes | Nausea and vomiting, etc. | |
Notes | Setting: Columbia, South America Dates: February 2014 to September 2016 Funding source: Industrial University of Santander (Universidad Industrial de Santander) (from trial reg) Declaration of interest: authors declared no conflicts of interest (reported in Spanish at end or publication) No data available in the Abstract. Publication in Portuguese/Spanish (?) with abstract in English. No translation as yet Trial registration form reported under Guiza 2016, but publication indicated the first author should be Parra‐Guiza We will try to get a translation or contact the authors for further information. |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Not reported in the abstract translation. |
Allocation concealment (selection bias) | Unclear risk | Not reported in the abstract translation. |
Blinding of participants and personnel (performance bias) All outcomes | Unclear risk | Not reported in the translated abstract |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Not reported in the translated abstract |
Incomplete outcome data (attrition bias) All outcomes | Unclear risk | No apparent loss of data after randomisation |
Selective reporting (reporting bias) | Unclear risk | They do not report on pruritus in the abstract, yet this is the secondary outcome in the trial registration form. However, we do not have a translation of the paper yet, nor have we seen the trial protocol. |
Other bias | Unclear risk | We were only able to assess the English abstract and so were unable to assess the whole paper. |